Verdict
Sardar Chemical Industries Limited (PSX: SARC) delivered a mixed FY2026 result. The manufacturing economics improved: gross profit rose despite slightly lower sales, operating profit increased, finance charges fell and profit before tax advanced by nearly one-third. But a much heavier tax charge reversed that progress below the line, leaving profit after tax and earnings per share lower. The clearest operating signal is therefore better cost absorption rather than stronger demand.
The result covers the audited standalone year ended June 30, 2026 and is presented in Pakistani rupees. SARC has no group consolidation in the published statements. The annual report was authorised by the board on September 28, 2026 and later transmitted through PSX on October 6, 2026. The figures below use the audited annual report, which agrees with the earlier PSX results filing on the core statements.
Results at a glance
- Net sales were PKR 528.55 million, down 1.0% from PKR 533.86 million.
- Gross profit increased 12.9% to PKR 167.58 million. Gross margin expanded to 31.7% from 27.8%, a gain of about 3.9 percentage points.
- Operating profit rose 17.6% to PKR 77.37 million, lifting operating margin to 14.6% from 12.3%.
- Finance charges fell 41.7% to PKR 7.27 million. Profit before tax increased 31.5% to PKR 70.32 million.
- Tax expense jumped to PKR 32.36 million from PKR 7.85 million. Profit after tax consequently fell 16.8% to PKR 37.96 million, and EPS declined to PKR 6.33 from PKR 7.60.
- The board recommended a final cash dividend of PKR 1.50 per share, equal to 15% of face value and about 24% of FY2026 EPS.
- Actual production declined to 422 tonnes from 467 tonnes, while rated capacity stayed at 660 tonnes. Utilisation fell to 64% from 71%.
AlphaGen model scores
The following are AlphaGen model outputs, not figures reported by SARC: Alpha QoQ Score: 9.00; TTM Performance Score: 22.92; 3Y Business Perf Score: 60.93; Sector Leadership Score: 21.4324. The weak near-term scores sit alongside a stronger three-year reading, which is consistent with a business that has expanded over time but ended FY2026 with softer volume and lower net earnings.
What improved
Gross economics did the heavy lifting
Sales dipped by only PKR 5.31 million, but cost of sales fell by PKR 24.48 million. That gap added PKR 19.17 million to gross profit. The audited notes show raw-material consumption declining 10.9% to PKR 258.71 million and fuel and power declining 18.8% to PKR 31.76 million. These reductions more than offset a 16.5% increase in production salaries and wages to PKR 51.77 million.
This is the most important arithmetic in the result. SARC produced fewer tonnes yet earned a wider gross margin, suggesting that lower input consumption, inventory movement and/or realised selling value per unit offset the volume decline. Net sales per tonne implied by the reported totals increased by roughly 9.5%, but this is only an inference: the company does not disclose a clean price, product-mix or volume bridge, so it should not be read as a verified price increase.
Management said imported raw-material prices, international fuel prices and local freight rose amid regional conflict, while customers struggled to absorb finished-product prices. That commentary explains the pressure on demand. It does not fully explain the improved reported gross margin, because the financial statements show lower total raw-material and fuel expense. The defensible conclusion is that lower reported cost of sales outweighed the modest sales decline; the precise split between procurement, product mix, inventory movements and pricing is not disclosed.
Operating and financing lines strengthened
Administrative and selling costs increased, but the gross-profit gain was large enough for operating profit to rise PKR 11.58 million. Other income increased to PKR 5.57 million, helped by a PKR 2.45 million profit on disposal of fixed assets. That gain is non-recurring and should not be treated as core operating improvement.
Finance charges dropped by PKR 5.21 million. The notes show lower mark-up on directors' loans and on the long-term loan, with lease mark-up also lower. This mattered because Pakistan's policy rate stood at 11.5% in June 2026 after an April increase, so the fall in SARC's finance cost was more company-specific than a simple consequence of easier monetary policy. Lower financing expense helped lift pretax margin to 13.3% from 10.0%.
What weakened / needs attention
Tax overwhelmed the pretax improvement
The tax line is the central weakness. Current-year tax expense was PKR 22.68 million and deferred tax was PKR 9.64 million, producing total tax expense of PKR 32.36 million. In FY2025, a PKR 6.52 million prior-year reversal reduced the tax charge to PKR 7.85 million. The effective tax burden therefore rose to about 46.0% of pretax profit from 14.7%.
This comparison shows why pretax and after-tax trends moved in opposite directions. Operating progress was real, but FY2025 benefited from a tax reversal and FY2026 absorbed both a larger current charge and deferred tax. Net margin fell to 7.2% from 8.5%, and the decline in EPS was therefore not caused by weaker gross profitability.
Lower production confirms soft demand
Production fell 9.6% and utilisation declined seven percentage points. The company says production is regulated to customer demand to avoid tying up cash in unnecessary inventory. That discipline limited the increase in stock-in-trade to 1.9%, but the lower utilisation rate also confirms that FY2026 was not a volume-led growth year.
The official FY2026 large-scale manufacturing release provides useful context: Pakistan's overall LSM output grew 4.98%, while chemical products were among the categories that declined. SARC's slightly lower revenue and reduced production are consistent with a difficult chemical-demand backdrop, although the national index cannot establish company-specific causality.
Receivables absorbed much of the cash generated before working capital
Cash generated before working-capital changes rose to PKR 88.43 million from PKR 78.35 million. Working capital then consumed PKR 37.67 million, led by a PKR 35.04 million increase in trade debts. Trade receivables ended the year at PKR 240.64 million, up 17.0%, even as sales declined slightly. Receivables now equal roughly 45.5% of annual sales, versus 38.5% a year earlier, making collection quality a material monitor.
After finance charges, worker participation payments and income tax, operating cash inflow was PKR 22.28 million, up from PKR 19.72 million. The statement labels this line as cash 'used' in operating activities, but the positive amount, the underlying additions and the reconciliation to closing cash all show an inflow. This appears to be a presentation error in the issuer's cash-flow caption, not a change in the arithmetic.
Capital expenditure increased sharply to PKR 14.86 million from PKR 2.86 million. After proceeds from asset disposals and long-term deposits, investing cash outflow was PKR 13.07 million. Operating cash less reported purchases of property, plant and equipment was therefore about PKR 7.42 million, down from PKR 16.85 million. Cash still increased modestly to PKR 23.37 million, but the combination of receivables growth and higher capex reduced financial flexibility.
Balance sheet and longer-run perspective
Current assets rose 8.6% to PKR 415.08 million while current liabilities declined 2.1% to PKR 77.22 million. The directly calculated current ratio was about 5.4 times, indicating ample short-term coverage. Equity increased 8.4% to PKR 373.71 million. The company's capital-risk note reports net debt of PKR 54.57 million, slightly below PKR 56.52 million a year earlier, and a gearing ratio of 13% versus 14%.
The balance sheet is liquid, but its composition matters. Cash is only PKR 23.37 million, while receivables and inventory together account for PKR 375.49 million. Strong headline liquidity therefore depends on converting customer balances and stock into cash. The audited report says customers are subject to credit ceilings and that exposure is spread across many parties; nevertheless, the year-end increase in receivables deserves more scrutiny than the current ratio alone suggests.
Over the longer run, net sales have nearly doubled from PKR 268 million in FY2019 to PKR 528.55 million in FY2026, an approximate compound growth rate of 10% a year. Profit after tax rose from PKR 18 million to PKR 37.96 million over the same period. Yet earnings peaked at about PKR 52 million in FY2024, and gross margins have ranged widely. The record points to genuine scale expansion but also a cyclical, input-sensitive earnings profile rather than smooth compounding.
Opportunities and risks
SARC manufactures dyestuffs and chemicals for leather, textile and paper users, including optical brighteners. Management is pursuing ZDHC MRSL conformity to meet environmental and chemical-safety requirements of export-oriented customers. Successful certification could improve access to buyers with tighter supply-chain standards, but the annual report provides no timetable, cost estimate or contracted revenue attached to the initiative.
The principal upside is straightforward: recovery in customer volumes while the improved gross-cost structure holds. Better receivable collection would turn more of operating profit into cash. Lower borrowings or financing spreads would also support pretax profit, although FY2026 already captured a substantial finance-cost reduction.
The risks are equally clear. Imported inputs and freight remain exposed to global energy and currency shocks; customer resistance to higher prices can depress utilisation; trade debts have grown faster than sales; and the tax rate can materially alter the translation from pretax profit to EPS. The company also has a single operating segment, so there is limited diversification if textile, leather or paper demand weakens together.
What to monitor next
- Production and utilisation: a recovery from 422 tonnes and 64% utilisation would provide the cleanest evidence of demand improvement.
- Gross margin durability: determine whether the 31.7% margin can hold when input prices, inventory movements and customer pricing normalise.
- Receivable days and cash collection: trade debts should not continue rising faster than sales.
- Tax normalisation: separate recurring current tax from deferred-tax movements and any prior-year adjustments.
- Capex returns: assess whether the FY2026 investment supports capacity, efficiency or compliance and whether it produces measurable cash benefits.
- ZDHC progress: look for certification, customer qualification or export orders rather than treating the initiative as completed.
Overall, FY2026 was operationally better than the EPS decline suggests. SARC protected gross profitability and reduced finance cost in a weak-volume year, but the improvement was diluted by tax and tied-up receivables. The next result needs to show that margin gains can coexist with volume recovery and stronger cash conversion.